BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Susceptibility of pentylenetetrazole-induced seizures in mice with Cereblon gene knockout

  • Jeon, Seung-Je (School of Life Sciences and Integrated Institute of Biomedical Research (IIBR), Gwangju Institute of Science and Technology (GIST)) ;
  • Ham, Jinsil (Department of Biomedical Science and Engineering (BMSE), Institute of Integrated Technology (IIT), Gwangju Institute of Science and Technology (GIST)) ;
  • Park, Chul-Seung (School of Life Sciences and Integrated Institute of Biomedical Research (IIBR), Gwangju Institute of Science and Technology (GIST)) ;
  • Lee, Boreom (Department of Biomedical Science and Engineering (BMSE), Institute of Integrated Technology (IIT), Gwangju Institute of Science and Technology (GIST))
  • Received : 2020.06.04
  • Accepted : 2020.08.11
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Epilepsy is a neurological disorder characterized by unpredictable seizures, which are bursts of electrical activity that temporarily affect the brain. Cereblon (CRBN), a DCAFs (DDB1 and CUL4-associated factors), is a well-established protein associated with human mental retardation. Being a substrate receptor of the cullin-RING E3 ubiquitin ligase (CRL) 4 complex, CRBN mediates ubiquitination of several substrates and conducts multiple biological processes. In the central nervous system, the large-conductance Ca2+-activated K+ (BKCa) channel, which is the substrate of CRBN, is an important regulator of epilepsy. Despite the functional role and importance of CRBN in the brain, direct injection of pentylenetetrazole (PTZ) to induce seizures in CRBN knock-out mice has not been challenged. In this study, we investigated the effect of PTZ in CRBN knock-out mice. Here, we demonstrate that, compared with WT mice, CRBN knock-out mice do not show the intensification of seizures by PTZ induction. Moreover, electroencephalography recordings were also performed in the brains of both WT and CRBN knockout mice to identify the absence of significant differences in the pattern of seizure activities. Consistently, immunoblot analysis for validating the protein level of the CRL4 complex containing CRBN (CRL4Crbn) in the mouse brain was carried out. Taken together, we found that the deficiency of CRBN does not affect PTZ-induced seizure.

Keywords

References

  1. Bozzi Y, Casarosa S and Caleo M (2012) Epilepsy as a neurodevelopmental disorder. Front Psychiatry 3, 19 https://doi.org/10.3389/fpsyt.2012.00019
  2. Jobe PC and Laird Ii HE (1987) Neurotransmitters and epilepsy, Springer Science & Business Media
  3. Zhu Y, Zhang S, Feng Y, Xiao Q, Cheng J and Tao J (2018) The Yin and Yang of BK channels in epilepsy. CNS Neurol Disord Drug Targets 17, 272-279 https://doi.org/10.2174/1871527317666180213142403
  4. Hansen SL, Sperling BB and Sanchez C (2004) Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Prog Neuro psychopharmacol Biol Psychiatry 28, 105-113 https://doi.org/10.1016/j.pnpbp.2003.09.026
  5. Ferraro TN, Golden GT, Smith GG et al (1999) Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 19, 6733-6739 https://doi.org/10.1523/jneurosci.19-16-06733.1999
  6. Harai T, Inoue R, Fujita Y et al (2012) Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice. Epilepsy Res 102, 180-187 https://doi.org/10.1016/j.eplepsyres.2012.06.001
  7. Liu J, Ye J, Zou X et al (2014) CRL4A(CRBN) E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis. Nat Commun 5, 3924 https://doi.org/10.1038/ncomms4924
  8. Higgins JJ, Pucilowska J, Lombardi RQ and Rooney JP (2004) A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 63, 1927-1931 https://doi.org/10.1212/01.WNL.0000146196.01316.A2
  9. Ito T, Ando H, Suzuki T et al (2010) Identification of a primary target of thalidomide teratogenicity. Science 327, 1345-1350 https://doi.org/10.1126/science.1177319
  10. Lopez-Girona A, Mendy D, Ito T et al (2012) Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia 26, 2326-2335 https://doi.org/10.1038/leu.2012.119
  11. Lee KM, Jo S, Kim H, Lee J and Park CS (2011) Functional modulation of AMP-activated protein kinase by cereblon. Biochim Biophys Acta 1813, 448-455 https://doi.org/10.1016/j.bbamcr.2011.01.005
  12. Nguyen TV, Lee JE, Sweredoski MJ et al (2016) Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon. Mol Cell 61, 809-820 https://doi.org/10.1016/j.molcel.2016.02.032
  13. Robinson SR (2000) Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem Int 36, 471-482 https://doi.org/10.1016/S0197-0186(99)00150-3
  14. Mates JM, Campos-Sandoval JA, Santos-Jimenez JL and Marquez J (2019) Dysregulation of glutaminase and glutamine synthetase in cancer. Cancer Lett 467, 29-39 https://doi.org/10.1016/j.canlet.2019.09.011
  15. Hohberger B and Enz R (2009) Cereblon is expressed in the retina and binds to voltage-gated chloride channels. FEBS Lett 583, 633-637 https://doi.org/10.1016/j.febslet.2009.01.018
  16. Pedersen TH, Riisager A, de Paoli FV, Chen TY and Nielsen OB (2016) Role of physiological ClC-1 Cl- ion channel regulation for the excitability and function of working skeletal muscle. J Gen Physiol 147, 291-308 https://doi.org/10.1085/jgp.201611582
  17. Kang JA, Park SH, Jeong SP et al (2016) Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A 113, 8771-8776 https://doi.org/10.1073/pnas.1502166113
  18. Jo S, Lee KH, Song S, Jung YK and Park CS (2005) Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J Neurochem 94, 1212-1224 https://doi.org/10.1111/j.1471-4159.2005.03344.x
  19. Lee KM, Yang SJ, Kim YD et al (2013) Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice. Diabetes 62, 1855-1864 https://doi.org/10.2337/db12-1030
  20. Choi TY, Lee SH, Kim YJ et al (2018) Cereblon maintains synaptic and cognitive function by regulating BK channel. J Neurosci 38, 3571-3583 https://doi.org/10.1523/jneurosci.2081-17.2018
  21. Fischer ES, Bohm K, Lydeard JR et al (2014) Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512, 49-53 https://doi.org/10.1038/nature13527
  22. Wu C, Orozco C, Boyer J et al (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10, 1-8 https://doi.org/10.1186/gb-2009-10-1-r1
  23. Bulatov E and Ciulli A (2015) Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation. Biochem J 467, 365-386 https://doi.org/10.1042/BJ20141450
  24. Lee J and Zhou P (2007) DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell 26, 775-780 https://doi.org/10.1016/j.molcel.2007.06.001
  25. Angers S, Li T, Yi X, MacCoss MJ, Moon RT and Zheng N (2006) Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 443, 590-593 https://doi.org/10.1038/nature05175
  26. Pines A, Dijk M, Makowski M et al (2018) TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A. Nat Commun 9, 1040 https://doi.org/10.1038/s41467-018-03484-6
  27. Dias J, Van Nguyen N, Georgiev P et al (2014) Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex. Genes Dev 28, 929-942 https://doi.org/10.1101/gad.240200.114
  28. Shi Q and Chen L (2017) Cereblon: a protein crucial to the multiple functions of immunomodulatory drugs as well as cell metabolism and disease generation. J Immunol Res 2017, 9130608
  29. Lupas AN, Zhu H and Korycinski M (2015) The thalidomidebinding domain of cereblon defines the CULT domain family and is a new member of the beta-tent fold. PLoS Comput Biol 11, e1004023 https://doi.org/10.1371/journal.pcbi.1004023
  30. Han Y, Rajadhyaksha AM, Mailloux AW et al (2013) Characterization of RING finger E3-ubiquitin ligase cereblon in hematopoietic regulation. Blood 122, 1207-1207 https://doi.org/10.1182/blood.v122.21.1207.1207
  31. Schneider CA, Rasband WS and Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671-675 https://doi.org/10.1038/nmeth.2089